Ledger.Open graph →
SEC Form D · Amendment · filed June 20, 2023

Biopharmaceutical Research Co

Offering
$23.2M
Sold
$23.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CASTROVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Edward H. Goodwin · Castroville, CADirectorGeorge B. Hodgin · Castroville, CAExec · DirectorCharles B. Schumacher · Castroville, CADirectorVictor Cho · Seattle, WADirectorRobert Hillman · Del Mar, CAExec · DirectorStephen Kurz · New York, NYDirectorDaniel M. Green · Greenwich, CTDirectorScott W. Corkery · Greenwich, CTExec · DirectorMatthew J. Edmonds · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗